Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Pharmacogenomics|June 9, 2016
Common genetic variants in platelet surface receptors and its association with ischemic strokeLukasz Milanowski, Justyna Pordzik, Piotr K Janicki, et al.
Annals of Agricultural and Environmental Medicine : AAEM|December 31, 2019
The role of acetylsalicylic acid and circulating microRNAs in primary prevention of cardiovascular events in patients with Diabetes Mellitus Type 2 - A ReviewAleksandra Chabior, Justyna Pordzik, Dagmara Mirowska-Guzel, et al.
Clinical Pharmacology and Therapeutics|May 6, 2019
Effectiveness of Antiplatelet Drugs Under Therapeutic Hypothermia: A Comprehensive ReviewCeren Eyileten, Aleksandra Soplinska, Justyna Pordzik, et al.
Vascular Pharmacology|January 28, 2019
Switching between P2Y<sub>12</sub> antagonists - From bench to bedsideAleksandra Gasecka, Michał Konwerski, Justyna Pordzik, et al.
Cardiovascular Diabetology|September 1, 2019
Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and reviewJustyna Pordzik, Daniel Jakubik, Joanna Jarosz-Popek, et al.
Molecular Medicine Reports|March 1, 2019
Increased burden of rare deleterious variants of the KCNQ1 gene in patients with large‑vessel ischemic strokePiotr K Janicki, Ceren Eyileten, Victor Ruiz-Velasco, et al.
Diabetes/Metabolism Research and Reviews|November 18, 2018
Resistin is a prognostic factor for death in type 2 diabetesAgnieszka Kapłon-Cieślicka, Agata Tymińska, Marek Rosiak, et al.
International Journal of Molecular Sciences|December 14, 2017
Population-Specific Associations of Deleterious Rare Variants in Coding Region of P2RY1-P2RY12 Purinergic Receptor Genes in Large-Vessel Ischemic Stroke PatientsPiotr K Janicki, Ceren Eyileten, Victor Ruiz-Velasco, et al.
Pageof 2